233 related articles for article (PubMed ID: 11051031)
1. AGEs and carbonyl stress: potential pathogenetic factors of long-term uraemic complications.
Zoccali C; Mallamaci F; Tripepi G
Nephrol Dial Transplant; 2000; 15 Suppl 2():7-11. PubMed ID: 11051031
[TBL] [Abstract][Full Text] [Related]
2. Implication of carbonyl stress in long-term uraemic complications.
Wada T; Miyata T; Kurokawa K
Nephrol Dial Transplant; 1999; 14 Suppl 1():79-81. PubMed ID: 10048461
[TBL] [Abstract][Full Text] [Related]
3. 'Carbonyl stress' and dialysis-related amyloidosis.
Miyata T; Ueda Y; Saito A; Kurokawa K
Nephrol Dial Transplant; 2000; 15 Suppl 1():25-8. PubMed ID: 10737163
[TBL] [Abstract][Full Text] [Related]
4. Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications.
Miyata T; van Ypersele de Strihou C; Kurokawa K; Baynes JW
Kidney Int; 1999 Feb; 55(2):389-99. PubMed ID: 9987064
[TBL] [Abstract][Full Text] [Related]
5. Oxidative protein damage with carbohydrates and lipids in uremia: 'Carbonyl stress'.
Inagi R; Miyata T
Blood Purif; 1999; 17(2-3):95-8. PubMed ID: 10449866
[TBL] [Abstract][Full Text] [Related]
6. Carbonyl stress: increased carbonyl modification of tissue and cellular proteins in uremia.
Miyata T; Izuhara Y; Sakai H; Kurokawa K
Perit Dial Int; 1999; 19 Suppl 2():S58-61. PubMed ID: 10406495
[TBL] [Abstract][Full Text] [Related]
7. Implication of the glycoxidation and lipoxidation reactions in the pathogenesis of dialysis-related amyloidosis (Review).
Sugiyama S; Miyata T; Inagi R; Kurokawa K
Int J Mol Med; 1998 Nov; 2(5):561-5. PubMed ID: 9858652
[TBL] [Abstract][Full Text] [Related]
8. Relevance of oxidative and carbonyl stress to long-term uremic complications.
Miyata T; Kurokawa K; van Ypersele de Strihou C
Kidney Int Suppl; 2000 Aug; 76():S120-5. PubMed ID: 10936808
[TBL] [Abstract][Full Text] [Related]
9. Ultrapure dialysate decreases plasma pentosidine, a marker of "carbonyl stress".
Izuhara Y; Miyata T; Saito K; Ishikawa N; Kakuta T; Nangaku M; Yoshida H; Saito A; Kurokawa K; van Ypersele de Strihou C
Am J Kidney Dis; 2004 Jun; 43(6):1024-9. PubMed ID: 15168382
[TBL] [Abstract][Full Text] [Related]
10. [Reduction of carbonyl stress with renal replacement therapy in chronic renal failure].
Słowik-Zyłka D
Ann Acad Med Stetin; 2004; 50(2):5-15. PubMed ID: 16529161
[TBL] [Abstract][Full Text] [Related]
11. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C
Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation and lipoxidation end products: reactive carbonyl compounds-related uraemic toxicity.
Miyata T; Saito A; Kurokawa K; van Ypersele de Strihou C
Nephrol Dial Transplant; 2001; 16 Suppl 4():8-11. PubMed ID: 11402090
[TBL] [Abstract][Full Text] [Related]
13. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?
Miyata T; Fu MX; Kurokawa K; van Ypersele de Strihou C; Thorpe SR; Baynes JW
Kidney Int; 1998 Oct; 54(4):1290-5. PubMed ID: 9767546
[TBL] [Abstract][Full Text] [Related]
14. Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure.
Miyata T; Maeda K; Kurokawa K; van Ypersele de Strihou C
Nephrol Dial Transplant; 1997 Feb; 12(2):255-8. PubMed ID: 9132640
[TBL] [Abstract][Full Text] [Related]
15. Protein-bound uraemic toxins, dicarbonyl stress and advanced glycation end products in conventional and extended haemodialysis and haemodiafiltration.
Cornelis T; Eloot S; Vanholder R; Glorieux G; van der Sande FM; Scheijen JL; Leunissen KM; Kooman JP; Schalkwijk CG
Nephrol Dial Transplant; 2015 Aug; 30(8):1395-402. PubMed ID: 25862762
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia.
Miyata T; Ueda Y; Yamada Y; Izuhara Y; Wada T; Jadoul M; Saito A; Kurokawa K; van Ypersele de Strihou C
J Am Soc Nephrol; 1998 Dec; 9(12):2349-56. PubMed ID: 9848790
[TBL] [Abstract][Full Text] [Related]
17. Concentrations of pentosidine, an advanced glycation end-product, in umbilical cord blood.
Tsukahara H; Ohta N; Sato S; Hiraoka M; Shukunami K; Uchiyama M; Kawakami H; Sekine K; Mayumi M
Free Radic Res; 2004 Jul; 38(7):691-5. PubMed ID: 15453634
[TBL] [Abstract][Full Text] [Related]
18. Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy.
Miyata T; Sugiyama S; Suzuki D; Inagi R; Kurokawa K
Kidney Int Suppl; 1999 Jul; 71():S54-6. PubMed ID: 10412738
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis, pathogenesis, and treatment of dialysis-related amyloidosis.
Miyata T; Inagi R; Kurokawa K
Miner Electrolyte Metab; 1999; 25(1-2):114-7. PubMed ID: 10207272
[TBL] [Abstract][Full Text] [Related]
20. Alterations of non-enzymatic biochemistry in uremia, diabetes, and atherosclerosis ("carbonyl stress").
Miyata T
Bull Mem Acad R Med Belg; 2002; 157(3-4):189-96; discussion 196-8. PubMed ID: 12508715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
